Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond
University of Montenegro · International Hellenic University · +6 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
9
total citations
- FWCI
- 137.64
- Percentile
- 100%
- References
- 289
Too recent for citation history.
Authors
6- EMEmir MuzurovićCorresponding
University of Montenegro
- NKNiki Katsiki
International Hellenic University, European University Cyprus
- ŠVŠpela Volčanšek
Ljubljana University Medical Centre
- FPFulvio Plescia
University of Palermo
- MRManfredi Rizzo
Department of Health, Mohammed Bin Rashid University of Medicine and Health Sciences
Topics & keywords
Topics
Keywords
- Lixisenatide
- Incretin
- Clinical trial
- Exenatide
- Diabetes mellitus
- Drug development
- Disease
- Obesity
No related works found for this paper.